Avexa in $60m HIV bid
http://www.gbmnews.com/articles/2/1/Avexa-in-60m-HIV-bid/Page1.html
News Hound
Your servent relentlessly hunting for interesting news stories around the world. By News Hound
Published on 03/19/2007
BIOTECH Avexa is hoping to raise up to $60 million to take its HIV-Aids drug Apricitabine to commercial production.
Avexa went into a trading halt on Friday pending yesterday's announcement of the outcome of phase IIb trials of the drug in patients in Australia, the United States and Argentina.